RELAPSING REMITTING MULTIPLE SCLEROSIS
Clinical trials for RELAPSING REMITTING MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new RELAPSING REMITTING MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for RELAPSING REMITTING MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with MS: major trial tests two leading treatments
Disease control OngoingThis study compares two existing medications for children and adolescents with relapsing-remitting multiple sclerosis (MS). It aims to see if ocrelizumab (given by infusion every 6 months) works better and is as safe as fingolimod (a daily pill) at preventing MS attacks. The tria…
Matched conditions: RELAPSING REMITTING MULTIPLE SCLEROSIS
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Experimental cell treatment aims to calm MS Flare-Ups
Disease control OngoingThis study is testing whether adding a special immune cell therapy (called TolDec) to standard MS medications can better control the disease. The therapy involves taking a patient's own cells, modifying them in a lab, and reinfusing them to help calm the overactive immune respons…
Matched conditions: RELAPSING REMITTING MULTIPLE SCLEROSIS
Phase: PHASE2 • Sponsor: Judit Pich • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Blood test may guide better MS treatment decisions
Disease control OngoingThis study is for people with relapsing-remitting multiple sclerosis (MS) who have been stable on their current medication for at least a year. It aims to find out if switching to a different drug called ofatumumab is better at keeping the disease quiet than staying on their curr…
Matched conditions: RELAPSING REMITTING MULTIPLE SCLEROSIS
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Can diet and exercise rival MS drugs? new study investigates
Disease control OngoingThis study aims to find out if a comprehensive lifestyle program—including a specific diet, exercise, and stress reduction—can be as effective as standard drug treatments for people newly diagnosed with multiple sclerosis (MS) or its early stage (CIS). It follows 44 participants …
Matched conditions: RELAPSING REMITTING MULTIPLE SCLEROSIS
Phase: NA • Sponsor: Terry L. Wahls • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC